questionText: To ask the Secretary of State for Health and Social Care, what assessment he has made of the extent of regional inequities in the provision of early access programmes for (a) innovative treatments and (b) people living with SOD1 motor neurone disease.
answerText: Company-led early access programmes (EAPs) are not endorsed by the Department or NHS England and no assessment has been made of whether there are regional inequities in the provision of early access programmes for innovative treatments and people living w...
heading: Motor Neurone Disease: Health Services